Article Text
PDFClinical ethics
Commentary
Shades of grey
Statistics from Altmetric.com
Footnotes
-
Funding DW was supported for this work by an early career fellowship from the Australian National Health and Medical Research Council [1016641].
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.
-
↵i This is a composite case. Names and details have been changed.
Linked Articles
- Clinical ethics
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Counselling variation among physicians regarding intestinal transplant for short bowel syndrome
- Survey of UK clinicians’ approaches to decision making in neonatal intestinal failure
- Neurodevelopmental impairment in necrotising enterocolitis survivors: systematic review and meta-analysis
- Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism
- Evaluation of portal venous gas detected by ultrasound examination for diagnosis of necrotising enterocolitis
- T and Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness, and effectiveness of testing
- Outcome of very premature infants with necrotising enterocolitis cared for in centres with or without on site surgical facilities
- Neonatal outcomes following early fetal growth restriction: a subgroup analysis of the EVERREST study
- Effect of birth weight on the association between necrotising enterocolitis and red blood cell transfusions in ≤1500 g infants
- Factors associated with the increased incidence of necrotising enterocolitis in extremely preterm infants in Sweden between two population-based national cohorts (2004–2007 vs 2014–2016)